JP2009525266A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009525266A5 JP2009525266A5 JP2008549057A JP2008549057A JP2009525266A5 JP 2009525266 A5 JP2009525266 A5 JP 2009525266A5 JP 2008549057 A JP2008549057 A JP 2008549057A JP 2008549057 A JP2008549057 A JP 2008549057A JP 2009525266 A5 JP2009525266 A5 JP 2009525266A5
- Authority
- JP
- Japan
- Prior art keywords
- vernonia
- use according
- oil
- wound
- scratch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 5
- 241000736800 Vernonia Species 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 200000000019 wound Diseases 0.000 claims 4
- 241001649137 Vernonia galamensis Species 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- CCPPLLJZDQAOHD-BEBBCNLGSA-N (-)-vernolic acid Chemical compound CCCCC[C@@H]1O[C@@H]1C\C=C/CCCCCCCC(O)=O CCPPLLJZDQAOHD-BEBBCNLGSA-N 0.000 claims 1
- 208000006641 Skin Disease Diseases 0.000 claims 1
- 238000005299 abrasion Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000699 topical Effects 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Claims (7)
- 創傷の治癒を向上させるための薬剤の調製においてベルノニアガラメンシス種子の抽出によって得られるエポキシ化化合物の利用であって、前記創傷は擦り傷、切り傷、引っ掻き傷または火傷であることを特徴とする利用。
- 創傷は哺乳動物の皮膚に生じたものであることを特徴とする請求項１に記載の利用。
- エポキシ化化合物はベルノニアガラメンシス種子由来の油性物、エステルまたは蝋性物あるいは前記油性物、エステルまたは蝋性物の成分であることを特徴とする請求項２に記載の利用。
- エポキシ化化合物はベルノニアガラメンシス種子由来のベルノニアオイルまたは該オイルの成分であることを特徴とする請求項３記載の利用。
- ベルノニアオイルは純化ベルノニアオイルであることを特徴とする請求項４記載の利用。
- エキポシ化化合物はベルノリン酸またはベルノニアオイルであることを特徴とする請求項２〜４のいずれかに記載の利用。
- 創傷によって生じた皮膚の疾患の再発予防または再発可能性の低減を図るために哺乳動物の皮膚に対して局所投与する予防治療のための皮膚軟化剤組成物の調製においてベルノニアガラメンシス種子の抽出により得られるエポキシ化化合物の利用であって、前記創傷は、擦り傷、切り傷、引っ掻き傷または火傷であることを特徴とする利用。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0600134.1 | 2006-01-05 | ||
| GBGB0600134.1A GB0600134D0 (en) | 2006-01-05 | 2006-01-05 | Use of epoxidised molecules |
| PCT/GB2007/000022 WO2007077452A2 (en) | 2006-01-05 | 2007-01-05 | Use of epoxidised compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009525266A JP2009525266A (ja) | 2009-07-09 |
| JP2009525266A5 true JP2009525266A5 (ja) | 2010-02-18 |
| JP5232974B2 JP5232974B2 (ja) | 2013-07-10 |
Family
ID=35911412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008549057A Expired - Fee Related JP5232974B2 (ja) | 2006-01-05 | 2007-01-05 | エポキシ化化合物の利用法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7803409B2 (ja) |
| EP (1) | EP1978982A2 (ja) |
| JP (1) | JP5232974B2 (ja) |
| CN (1) | CN101365464A (ja) |
| BR (1) | BRPI0706837A2 (ja) |
| GB (2) | GB0600134D0 (ja) |
| WO (1) | WO2007077452A2 (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2683731A1 (en) * | 2007-04-17 | 2008-10-23 | Bayer Consumer Care Ag | Use of vernonia extract |
| IL183084A0 (en) * | 2007-05-09 | 2007-09-20 | Trans Biodisel Ltd | Modified-immobilized enzymes of high tolerance to hydrophilic substrates in organic media |
| GB2460445B (en) * | 2008-05-30 | 2012-07-11 | Vernolix Ltd | Treatment of ringworm |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE91617C (ja) | ||||
| ZA713539B (en) | 1970-06-23 | 1972-02-23 | Hoffmann La Roche | Pharmaceutical compositions |
| FR2710524B1 (fr) * | 1993-09-28 | 1995-11-17 | Oreal | Composition de vernis à ongles contenant une huile époxydée comme plastifiant. |
| US5693327A (en) * | 1995-07-12 | 1997-12-02 | Shah; Eladevi | Herbal compositions |
| US6180668B1 (en) * | 1997-12-18 | 2001-01-30 | Fan Tech Ltd | Reconstituted meadowfoam oil in personal care applications |
| GB9815177D0 (en) * | 1998-07-13 | 1998-09-09 | King S College London | Treatment of skin disorders |
| US6680391B2 (en) * | 1998-07-13 | 2004-01-20 | Btg International Limited | Treatment of skin conditions |
| US6346251B1 (en) | 1999-06-15 | 2002-02-12 | Mark Zamoyski | Compositions and methods for treating psoriasis |
| GB2353706A (en) | 1999-09-03 | 2001-03-07 | Eladevi Shah | Herbal composition for the treatment of skin disorders and fungal infections of the skin and nails |
| AU2002226644B2 (en) * | 2001-01-16 | 2006-11-09 | Ben Gurion University Of The Negev, Research And Development Authority | Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| AU2002353485B2 (en) | 2001-12-04 | 2009-01-15 | Ben Gurion University Of The Negev Research And Development Authority | Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| GB2411114B (en) | 2004-02-19 | 2006-08-16 | Phynova Ltd | A botanical drug or dietary supplement |
-
2006
- 2006-01-05 GB GBGB0600134.1A patent/GB0600134D0/en not_active Ceased
-
2007
- 2007-01-03 US US11/650,205 patent/US7803409B2/en not_active Expired - Fee Related
- 2007-01-04 GB GB0700179A patent/GB2433888B/en not_active Expired - Fee Related
- 2007-01-05 WO PCT/GB2007/000022 patent/WO2007077452A2/en active Application Filing
- 2007-01-05 CN CNA2007800019097A patent/CN101365464A/zh active Pending
- 2007-01-05 EP EP07700327A patent/EP1978982A2/en not_active Withdrawn
- 2007-01-05 JP JP2008549057A patent/JP5232974B2/ja not_active Expired - Fee Related
- 2007-01-05 BR BRPI0706837-9A patent/BRPI0706837A2/pt not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201101243A1 (ru) | 3h-имидазо[4,5-c]пиридин-6-карбоксамиды в качестве противовоспалительных средств | |
| WO2006037031A3 (en) | Formulations and methods for treatment of inflammatory diseases | |
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| WO2007093183A3 (en) | Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases | |
| JP2007523049A5 (ja) | ||
| WO2011106729A3 (en) | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents | |
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| JP2012532093A5 (ja) | ||
| CL2012001056A1 (es) | Compuestos derivados de cromenona sustituidos, inhibidores de enzimas pi 3 quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion de trastornos de proliferacion celular, tales como tumores enfermedades inflamatorias y fibroticas, asma, diabetes insulinodependiente, entre otras. | |
| GT200900095A (es) | Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas. | |
| ECSP066770A (es) | Nuevos ésteres de quinuclidina cuaternizados | |
| JP2007238598A5 (ja) | ||
| CR9721A (es) | Compuestos de carbamato para utilizar en el tratamiento de desordenes neurodegenerativos | |
| NZ594184A (en) | Skin treatment | |
| WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
| JP2012508256A5 (ja) | ||
| HRP20131229T1 (hr) | Lijeäśenje ateroskleroze | |
| JP2009525266A5 (ja) | ||
| EA201270653A1 (ru) | Антагонист dpи его применение | |
| EA201270747A1 (ru) | Композиции и способы для профилактики и лечения ран | |
| JP2008508354A5 (ja) | ||
| ES2578729T3 (es) | Agente terapéutico para enfermedades relacionadas con el hígado | |
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| EA201171229A1 (ru) | Терапевтическое применение производных хиназолиндиона при сердечно-сосудистых заболеваниях | |
| BRPI0818822A2 (pt) | Forma amorfa de um composto anti-inflamatório |